Literature DB >> 33375505

Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?

Susan Brandenburg1, Anne Blank1, Alexander D Bungert1, Peter Vajkoczy1,2.   

Abstract

For decades, it has been known that the tumor microenvironment is significant for glioma progression, namely the infiltration of myeloid cells like microglia and macrophages. Hence, these cell types and their specific tasks in tumor progression are subject to ongoing research. However, the distribution of the brain resident microglia and the peripheral macrophages within the tumor tissue and their functional activity are highly debated. Results depend on the method used to discriminate between microglia and macrophages, whereby this specification is already difficult due to limited options to distinguish between these both cell populations that show mostly the same surface markers and morphology. Moreover, there are indications about various functions of microglia and macrophages but again varying on the method of discrimination. In our review, we summarize the current literature to determine which methods have been applied to differentiate the brain resident microglia from tumor-infiltrated macrophages. Furthermore, we compiled data about the proportion of microglia and macrophages in glioma tissues and ascertained if pro- or anti-tumoral effects could be allocated to one or the other myeloid cell population. Recent research made tremendous efforts to distinguish microglia from recruited macrophages. For future studies, it could be essential to verify which role these cells play in brain tumor pathology to proceed with novel immunotherapeutic strategies.

Entities:  

Keywords:  glioma; myeloid cells; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 33375505      PMCID: PMC7794706          DOI: 10.3390/ijms22010194

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  144 in total

1.  The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.

Authors:  Makiko Mizutani; Paula A Pino; Noah Saederup; Israel F Charo; Richard M Ransohoff; Astrid E Cardona
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

2.  Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells.

Authors:  Annett Müller; Susan Brandenburg; Kati Turkowski; Susanne Müller; Peter Vajkoczy
Journal:  Int J Cancer       Date:  2014-12-24       Impact factor: 7.396

3.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.

Authors:  B Badie; J M Schartner
Journal:  Neurosurgery       Date:  2000-04       Impact factor: 4.654

4.  Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus.

Authors:  Sergiy V Kushchayev; Yevgeniya S Kushchayeva; Philip C Wiener; Adrienne C Scheck; Behnam Badie; Mark C Preul
Journal:  World Neurosurg       Date:  2012-11-23       Impact factor: 2.104

5.  Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.

Authors:  Konrad Gabrusiewicz; Aleksandra Ellert-Miklaszewska; Maciej Lipko; Malgorzata Sielska; Marta Frankowska; Bozena Kaminska
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

6.  A novel microglial subset plays a key role in myelinogenesis in developing brain.

Authors:  Agnieszka Wlodarczyk; Inge R Holtman; Martin Krueger; Nir Yogev; Julia Bruttger; Reza Khorooshi; Anouk Benmamar-Badel; Jelkje J de Boer-Bergsma; Nellie A Martin; Khalad Karram; Isabella Kramer; Erik Wgm Boddeke; Ari Waisman; Bart Jl Eggen; Trevor Owens
Journal:  EMBO J       Date:  2017-09-28       Impact factor: 11.598

7.  A new genetic strategy for targeting microglia in development and disease.

Authors:  Gabriel L McKinsey; Carlos O Lizama; Amber E Keown-Lang; Abraham Niu; Nicolas Santander; Amara Larpthaveesarp; Elin Chee; Fernando F Gonzalez; Thomas D Arnold
Journal:  Elife       Date:  2020-06-23       Impact factor: 8.140

8.  Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma.

Authors:  Anne Blank; Irina Kremenetskaia; Ruth M Urbantat; Güliz Acker; Kati Turkowski; Josefine Radke; Ulf C Schneider; Peter Vajkoczy; Susan Brandenburg
Journal:  J Pathol       Date:  2020-11-24       Impact factor: 7.996

9.  Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology.

Authors:  Anat London; Inbal Benhar; Mary J Mattapallil; Matthias Mack; Rachel R Caspi; Michal Schwartz
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

10.  Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.

Authors:  Thecla A van Wageningen; Eva Vlaar; Gijs Kooij; Cornelis A M Jongenelen; Jeroen J G Geurts; Anne-Marie van Dam
Journal:  Acta Neuropathol Commun       Date:  2019-12-11       Impact factor: 7.801

View more
  10 in total

Review 1.  Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells.

Authors:  Xiaojin Liu; Yuan Liu; Yiwei Qi; Yimin Huang; Feng Hu; Fangyong Dong; Kai Shu; Ting Lei
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  The molecular feature of macrophages in tumor immune microenvironment of glioma patients.

Authors:  Hao Zhang; Yue-Bei Luo; Wantao Wu; Liyang Zhang; Zeyu Wang; Ziyu Dai; Songshan Feng; Hui Cao; Quan Cheng; Zhixiong Liu
Journal:  Comput Struct Biotechnol J       Date:  2021-08-14       Impact factor: 7.271

Review 3.  Glioblastoma Microenvironment and Cellular Interactions.

Authors:  Carmen-Bianca Crivii; Adina Bianca Boșca; Carmen Stanca Melincovici; Anne-Marie Constantin; Mariana Mărginean; Eleonora Dronca; Rada Suflețel; Diana Gonciar; Maria Bungărdean; Alina Șovrea
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

Review 4.  Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.

Authors:  Angelica Pace; Fabio Scirocchi; Chiara Napoletano; Ilaria Grazia Zizzari; Luca D'Angelo; Antonio Santoro; Marianna Nuti; Hassan Rahimi; Aurelia Rughetti
Journal:  Int J Mol Sci       Date:  2022-06-05       Impact factor: 6.208

5.  Macrophage depletion in stellate ganglia alleviates cardiac sympathetic overactivation and ventricular arrhythmogenesis by attenuating neuroinflammation in heart failure.

Authors:  Dongze Zhang; Wenfeng Hu; Huiyin Tu; Bryan T Hackfort; Bin Duan; Wanfen Xiong; Michael C Wadman; Yu-Long Li
Journal:  Basic Res Cardiol       Date:  2021-04-21       Impact factor: 17.165

Review 6.  Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.

Authors:  Johannes K Andersen; Hrvoje Miletic; Jubayer A Hossain
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

7.  Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro.

Authors:  Susan Brandenburg; Gueliz Acker; Ruth M Urbantat; Claudius Jelgersma; Peter Vajkoczy
Journal:  Oncol Rep       Date:  2022-07-20       Impact factor: 4.136

8.  Levetiracetam Suppresses the Infiltration of Neutrophils and Monocytes and Downregulates Many Inflammatory Cytokines during Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice.

Authors:  Taira Matsuo; Rie Komori; Minami Nakatani; Shiori Ochi; Aya Yokota-Nakatsuma; Junichi Matsumoto; Fuyuko Takata; Shinya Dohgu; Yasuhiro Ishihara; Kouichi Itoh
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

9.  The Dynamics of Tumor-Infiltrating Myeloid Cell Activation and the Cytokine Expression Profile in a Glioma Resection Site during the Post-Surgical Period in Mice.

Authors:  Jescelica Ortiz-Rivera; Alejandro Albors; Yuriy Kucheryavykh; Jeffrey K Harrison; Lilia Kucheryavykh
Journal:  Brain Sci       Date:  2022-07-07

Review 10.  Different phenotypes of microglia in animal models of Alzheimer disease.

Authors:  Yun Wei; Xianxiao Li
Journal:  Immun Ageing       Date:  2022-10-08       Impact factor: 9.701

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.